Showing results (1521-1530 of 1,558) with videos related to
Sort By:
Pageof 156
JCO Oncology Practice|March 25, 2026
Comparable Effectiveness of Weight-Based and Fixed-Dose Pembrolizumab in Non-Small Cell Lung Cancer: Insights From a National Real-World CohortEliya Shachar, Uriel Katz, Shir Barilier, et al.JCO Oncology Practice|April 30, 2026
Trends in Long-Term Survival Among Patients With De Novo Metastatic CancerSaad Badat, Braden Lau, Fang Wang, et al.JCO Oncology Practice|April 30, 2026
Real-World Treatment Patterns and Outcomes Among Patients With Newly Diagnosed AML in the United StatesElizabeth Dianne Pulte, Laura L Fernandes, Kelly Norsworthy, et al.JCO Oncology Practice|May 4, 2026
Immunomodulatory Agent Adherence Trajectories and Survival Among Older Patients With Multiple MyelomaRong Wang, Mengmeng Ji, Natalia Neparidze, et al.JCO Oncology Practice|March 20, 2026
Perceptions of Prognosis and Hope Among Patients With Advanced Cancer at the Time of Enrollment in an Early-Phase Clinical TrialMary C Boulanger, Debra M Lundquist, Andrea Pelletier, et al.JCO Oncology Practice|April 24, 2026
Provider Follow-Up and Adherence to Imaging Surveillance Recommendations for Lung Cancer Survivors in a Nationwide Health Care SystemJulie T Wu, Nicole Lin, Scott V Adams, et al.JCO Oncology Practice|April 23, 2026
Insurance Disparity in Novel Hormonal Therapy Initiation in Patients With Metastatic Hormone-Sensitive Prostate Cancer: Medicare Advantage Versus Traditional MedicareBaqir Jafry, Chuan Angel Lu, Jonathan Ji, et al.JCO Oncology Practice|May 12, 2026
Incidence, Risk Factors, and Impact of Immunotherapy on Brain Metastasis in Extensive-Stage Small Cell Lung Cancer Without Baseline Brain InvolvementWenli Cao, Xiangjuan Ma, Weiheng Hu, et al.JCO Oncology Practice|April 16, 2026
Liposomal Versus Conventional Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas: Observational Multi-Institutional Cohort of 8.5-Year ExperienceGabriel Aleixo, Lee Hartner, Mark Diamond, et al.JCO Oncology Practice|April 9, 2026
Feasibility Study: Early Experiences With a Cancer Center's Virtual Expert Medical Opinion ProgramAllison Lipitz-Snyderman, Susan Chimonas, Brendan Raftery, et al.Pageof 156